Research

Packages

Life of the unit

Next seminars

21 septembre 2018 Clémence Leyrat Problèmatique des données manquantes dans les analyses par score de propension

02 octobre 2018 Adélaïde Dousseau Is the sequential parallel comparison design an ethical way to tackle the "placebo response issue" in depression drug development?

Last publications

Updated

Buprenorphine prescription compliance: an original observational and longitudinal study

Auteurs

• Guillou-Landreat Morgane - Ecole doctorale Biologie-Santé - ED502 
  
  
• Sébille Véronique - PU-PH Biostatistique - Directrice de l'unité SPHERE  - Université de Nantes - UFR de Pharmacie 
  
  
• Victorri-Vigneau Caroline - MCU-PH Pharmacologie  - Université de Nantes - UFR de Médecine 
  
  
• Foucher Yohann - Maître de Conférences en Biostatistique - HDR  - UFR de médecine - Université de Nantes 
  
  
• Vénisse Jean-Luc - Professeur des Universités - Praticien Hospitalier  - UFR de Médecine - Université de Nantes - CHU Nantes 
  
  
• Jolliet Pascale - PU-PH Pharmacologie  - Université de Nantes - CHU Nantes 
  
  

Description

Nature : Articles dans une revue internationale
Thématique : Pharmacoépidémiologie
Rang : Rang A : publication porté par un membre de l'unité, dans le cadre de l'unité
Axe de recherche principal: Pharmacodépendance
Sujet : Etudes Cliniques avec ou sans financement hors PHRC et STIC

Guillou-Landreat M, Sébille V, Victorri-Vigneau C, Foucher Y, Vénisse JL, Jolliet P (2014) Buprenorphine prescription compliance: an original observational and longitudinal study. Journal of Psychoactive Drugs, 46(2): 162-7.

Lien

Abstract

INTRODUCTION: Buprenorphine is one of the main opioid dependence treatments, especially in France, where it has been widely prescribed since 1996. But it can easily be misused and its prescription has to be followed up. In the literature, we found several studies on buprenorphine, but we did not find long-term ecological follow-up studies on buprenorphine prescription and compliance. MATERIAL AND METHOD: The main purpose of this study was to define stability or instability of the prescription of buprenorphine to opiate-addicted patients. We carried out a forecast study on prescription of buprenorphine over a 10-year period, using software collecting prescription data. We performed statistical analysis of the conditions and transitions of opiate-addicted patients treated with buprenorphine along appointments. DISCUSSION/CONCLUSION: We showed that 70% of buprenorphine prescriptions are stable; we assumed that our results correspond to buprenorphine compliance. The retention in treatment was associated with a positive evolution of prescription stability. Prior criminal records were the only factor linked to instability. We showed that collecting precise prescription data in face to face appointments using software, including legal prescription rules that guide practitioners in following buprenorphine prescription compliance, seemed to be a useful method to measure buprenorphine compliance.

Publications sur le même sujet (Etudes Cliniques avec ou sans financement hors PHRC et STIC)

• Espitia O, Fouassier M, Hardouin JB, Pistorius MA, Planchon B, Trossaert M, Pottier P (2017) Thrombin Generation Assay in Hospitalized Nonsurgical Patients A New Tool to Assess Venous Thromboembolism Risk?. Clinical and Applied Thrombosis/Hemostasis, 23(1): 45-51.
  
  
• Lepère V, Vanier A, Loncar Y, Lemoine L, Vaillant J, Monsel A, Savier E, Coriat P, Eyraud D (2017) Risk factors for pulmonary complications after hepatic resection. Role of intraoperative hemodynamic instability and hepatic ischemia. , 17(1): 84.
  
  
• Molto A, Tézenas du Montcel S, Wendling D, Dougados M, Vanier A, Gossec L (2017) Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort. Annals of Rheumatic Diseases, 76(6): 1036-1041.
  
  
• Bernardeschi D, Pyatigorskaya N, Vanier A, Bielle F, Smail M, Sterkers O, Kalamarides M (2017) Role of electrophysiology to guide near-total resection for facial nerve function perservation in large vestibula schwanoma surgery. Journal of Neurosurgery: [Epub, ahead of print].
  
  
• Pasquier L, Kirouani M, Fanget F, Nomine C, Caillard C, Arnault V, Finel JB, Christou N, Mathonnet M, Trésallet C, Hamy A, de Calan L, Brunaud L, Menegaux F, Lifante JC, Hardouin JB, Drui D, Mirallié E, Blanchard C (2017) Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbeck's Archives of Surgery, 402(2): 309-314.
  
  
• Torres R, N'guyen Y, Vanier A, Smail M, Ferray E, Sterkers O, Kalamarides M, Bernardeschi D (2017) Multivariate Analysis of Factors Influencing Facial Nerve Outcome following Microsurgical Resection of Vestibular Schwannoma. Otolaryngology Head and Neck Surgery, 156(3): 525-533.
  
  
• De Seta D, N'guyen Y, Vanier A, Ferray E, Bebear J, Godey B, Robier A, Mondain M, Deguine O, Sterkers O, Mosnier I (2016) Five-Year Hearing Outcomes in Bilateral Simultaneously Cochlear-Implanted Adult Patients. Audiology Neurotology, 21: 261-67.
  
  
• Touhami S, Fardeau C, Vanier A, Zambrowski O, Steinborn R, Simon C, Tézenas du Montcel S, Bodaghi B, Le Hoang P (2016) Birdshot Retinochoroidopathy: Prognostic Factors of Long-term Visual Outcome. Americal Journal of Ophthalmology: [Epub ahead of print].
  
  
• Ali A, Carré A, Hassler C, Spilka S, Vanier A, Barry C, Berthoz S (2016) Risk factors for substances use and misuse among young people in France: What can we learn from the Substance Use Risk Profile Scale?. Drug and Alcohol Dependence, 163: 84-91.
  
  
• Brédart A, Merdy O, Sigal-Zafrani B, Fiszer C, Dolbeault S, Hardouin JB (2016) Identifying trajectory clusters in breast cancer survivors' supportive care needs, psychosocial difficulties, and resources from the completion of primary treatment to 8 months later.. Supportive Care in Cancer, 24(1): 357-366.
  
  
• Gross R, Leboeuf F, Hardouin JB, Perrouin-Verbe B, Brochard S, Remy-Neris O (2015) Does Muscle coactivation influence joint excursions during gait in children with and without hemiplegic cerebral palsy? Relationship between muscle coactivation and joint kinematics.. Clinical Biomechanics, 30(10): 1088-1093.
  
  
• Boutoleau-Bretonnière C, Evrard C, Hardouin JB, Rocher L, Charriau T, Etcharry-Bouyx F, Auriacombe M, Richard-Mornas A, Lebert F, Pasquier F, Sauvaget A, Bulteau S, Vercelletto M, Derkinderen P, Boutoleau-Bretonnière C, Thomas R (2015) DAPHNE: a new tool for diagnosis of behavioral variant of frontototemporal dementia. Dement Geriatr Cogn Dis Extra, 5(3): 503-516.
  
  
• Touhami S, Fardeau C, Vanier A, Knoeri J, Simon C, Tézenas du Montcel S, Troumani Y, Bodaghi B, Le Hoang P (2015) Visual Acuity in Birdshot Retinochoroidopathy Evaluation. Americal Journal of Ophthalmology, 160(4): 817-21.
  
  
• Jézéquel P, Loussouarn D, Guérin-Charbonnel C, Campion L, Vanier A, Gouraud W, Hamza L, Guette C, Valo I, Verrièle V, Campone M (2015) Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Research, 17: 43.
  
  
• Le Bourgeois A, Labopin M, Guillaume T, Foucher Y, Tessoulin B, Malard F, Ayari S, Peterlin P, Derenne S, Herry P, Cesbron A, Gagne K, Lodé L, Illiaquer M, Imbert-Marcille B, Le Gouil S, Moreau P, Mothy M, Chevallier P (2014) HHV-6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Experimental Hematology, 42(11): 945-54.
  
  
• Molinié F, Vanier A, Woronoff AS, Guizard AV, Delafosse P, Velten M, Daubisse-Marillac L, Arveux P, Tretarre B (2014) Trends in breast cancer incidence and mortality in France 1990–2008. Breast Cancer Research Treatment, 147(1): 167-75.
  
  
• Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou Y, Archambaud F, Rodien P, Henry JF, zarnegar R, Hardouin JB, Mirallié E (2013) Surgery for 'asymptomatic' mild primary hyperparathyroidism improves some clinical symptoms postoperatively. European Journal of Endocrinology, 169(5): 665-672.
  
  
• Vanier A, Leux C, Allioux C, Billon-Delacourt S, Lombrail P, Molinié F (2013) Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France). Cancer Epidemiology, 37(5): 683-87.
  
  
• Mantoo S, Meurette G, Wyart V, Hardouin JB, Crétolle C, Capito C, Sarnacki S, Podevin G, Lehur PA (2013) The impact of anorectal malformations on anorectal function and social integration in adulthood: report from a national database. Colorectal Disease, 15(6): e330-e335.
  
  
• Gross R, Leboeuf F, Hardouin JB, Lempereur M, Perrouin-Verbe B, Remy-Neris O, Brochard S (2013) The influence of gait speed on co-activation in unilateral spastic cerebral palsy children. Clinical Biomechanics, 28(3): 312–317.
  
  
• Le Bras M, Roquilly A, Deckert V, Langhi C, Feuillet F, Sébille V, Mahé PJ, Bach K, Masson D, Lagrost L, Costet P, Asehnoune K, Cariou B (2013) Plasma PCSK9 Is a Late Biomarker of Severity in Patients With Severe Trauma Injury. J Clin Endocrin Metab, 98(4): E732-736.
  
  
• Molinié F, Vanier A, Tretarre B, Guizard AV, Arveux P, Poillot ML, Woronoff AS, Velten M, Binder-Foucard F, Daubisse-Marillac L, Delafosse P (2012) Incidence du cancer in situ et invasif du sein en France (1990-2008) – Données des registres de cancer (réseau FRANCIM). Bulletin Epidémiologique Hebdomadaire InVS - Numéro Thématique, 35-36-37: 395-98.
  
  
• Vanier A, Paillé C, Abbey H, Berrut G, Lombrail P, Moret L (2011) Évaluation du risque iatrogénique médicamenteux des patients âgés hospitalisés en court-séjour. Ger Psychol Neuropsychiatr Vieil, 9(1): 51-7.
  
  

Publications ayant le même axe principal de recherche (Pharmacodépendance)

• Rousselet M, Feuillet F, Gérardin M, Jolliet P, Hardouin JB, Victorri-Vigneau C (2017) The French addictovigilance network clinical assessment: Z-drugs, true false twins. Expert Opinion on Drug safety, 16(9): 1063-1069.
  
  
• Von Theobald L, Rousselet M, Cholet J, Debar H, Boels D, Victorri-Vigneau C, Grall-Bronnec M (2017) Inpatient Gamma-Hydroxybutyrate detoxification: a case report describing day-to-day therapeutic management. Journal of addiction medicine, 11(3): 231-4.
  
  
• Etcheverrigaray F, Betaud C, Feuillet F, Grall-Bronnec M, Jolliet P, Victorri-Vigneau C (2016) Pharmacists’ different profiles characterization about opioid substitution treatments. Therapie, 71: 379-387.
  
  
• Péron E, Hardouin JB, Feuillet F, Wainstein L, Chaslerie A, Pivette J, Jolliet P, Victorri-Vigneau C (2016) Selective Serotonin Reuptake Inhibitors, are they all the same? a pharmacoepidemiological approach . Advances in Pharmacoepidemiology and Drug Safety, 5(3): 1000203.
  
  
• Victorri-Vigneau C, Hardouin JB, Rousselet M, Gérardin M, Guerlais M, Guillou-Landreat M, Grall-Bronnec M, Sébille V, Jolliet P, and the French Addictovigilance network (2016) Multicentre study for the validation of the French addictovigilance network reports assessment tool. British Journal of Clinical Pharmacology, 82: 1030-1039.
  
  
• Victorri-Vigneau C, Rousselet M, Grall-Bronnec M, Bouquié R, Belliot E, Guerlais M, Guillet JY, Jolliet P (2016) Use of Psychotropic Drug Urine Test Strips in Opiate Maintenance Therapy: A Clinical Assessment of Its Advantages. Substance Abuse, 37(4): 584-90.
  
  
• Gérardin M, Couec M, Grall-Bronnec M, Feuillet F, Wainstein L, Rousselet M, Perrouin F, Bonnot O, Drouineau MH, Jolliet P, Victorri-Vigneau C (2015) PHEDRE trial protocol – observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population. BMC Psychiatry, 15: 281.
  
  
• Guerlais M, Grall-Bronnec M, Feuillet F, Gérardin M, Jolliet P, Victorri-Vigneau C (2015) Dependence on prescription benzodiazépines and z-drugs among young to middle-aged patients in France. Subst Use Misuse, 50(3): 320-327.
  
  
• Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini J, Jolliet P, Victorri-Vigneau C (2015) Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections : a national French survey. Brit J Dermatol, 172: 10412-4.
  
  
• Bouquié R, Hernando H, Deslandes G, Ben Mostefa Daho A, Renaud C, Grall-Bronnec M, Dailly E, Jolliet P (2015)
  
  
• Darnis D, Allain-Veyrac G, Jolliet P (2014) The special case of diclofenac. Enliven Archive : .
  
  
• Bouquié R, Deslandes G, Nieto-Bernaldez B, Renaud C, Dailly E, Jolliet P (2014) A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy . Anal Methods , 6: 178-186.
  
  
• Allavena C, Dailly E, Reliquet V, Bonnet B, Pineau S, Andre-Garnier E, Boutoille D, Bouquié R, Raveleau A, Bouchez S, Billaud E, Raffi F (2014) Switching from Tenofovir/Emtricitabine and Nevirapine to Tenofovir/Emtricitabine/Rilpivirine Single Tablet Regimen in Virologically Suppressed, HIV-1 Infected Subjects . J Antimicrob Chemother, 69: 2804-2808.
  
  
• Gregoire M, Deslandes G, Renaud C, Bouquié R, Allavena C, Raffi F, Jolliet P, Dailly E (2014)
  
  
• Dailly E, Allavena C, Deslandes G, Bouquié R, Jolliet P, Raffi F (2014) Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV . Curr Clin Pharmacol., 9: 399-403.
  
  
• Victorri-Vigneau C, Gérardin M, Rousselet M, Guerlais M, Grall-Bronnec M, Jolliet P (2014) An update on zolpidem abuse and dependence . J Addict Dis. , 33: 15-23.
  
  
• Bouquié R, Wainstein L, Pilet P, Mussini J, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C (2014) Crushed and injected buprenorphine tablets : characteristics of princeps and generic solutions. Plos One, 9: e113991.
  
  
• Victorri-Vigneau C, Collin C, Messina-Gourlot M, Raffournier C, Mallaret M, Besse J, Courné MA, Richard N, Sébille V, Arnaud P, participants of expert group of the study (2014) Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opin Drug Deliv, 11(7): 995-1004.
  
  
• Cheron-Blumel A, Grall-Bronnec M, Victorri-Vigneau C, Péron E, Betaud C, Jolliet P, Amar M (2014) Prescription of methylphenidate for children : importance of recommendations to limit misuse. Arch Pediatr, 21: 852-9.
  
  
• Etcheverrigaray F, Cholet J, Sauvaget A, Guerlais M, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C (2014) Thiocolchicoside and alcohol abstinence: a case report . Alcohol Alcohol, 49: 486-7.
  
  
• Rat C, Penhouet G, Gaultier A, Chaslerie A, Pivette J, NGuyen JM, Victorri-Vigneau C (2014) Did the new French pay-for-performance system modify benzodiazepine prescribing practices? A description based on the prospective follow-up of two historical cohorts. BMC Health Serv Res, 14: 301.
  
  
• Gregoire M, Boutoleau-Bretonnière C, Deslandes G, Monteil-Ganière C, Bouquié R, Dailly E, Renaud C, Azoulay C, Pineau A, Grison-Hernando H, Jolliet P (2014) Early lactic acidosis following massive acetaminophen poisoning: a metabolic disorder sometimes unknown [L’acidose lactique précoce lors de l’intoxication massive au paracetamol: un trouble métabolique parfois méconnu] . Toxicologie Analytique et Clinique : sous presse.
  
  
• Deslandes G, Bouquié R, Boels D, Gregoire M, Grison-Hernando H, Azoulay C, Pineau A, Monteil-Ganière C, Renaud C, Dailly E, Harry P, Jolliet P (2014) Accidental poisoning with brimonidine eye drops in a 9-day-old infant . Toxicologie Analytique et Clinique : sous presse.
  
  
• Guerlais M, Victorri-Vigneau C, Jolliet P (2014) Mécanismes de l’addiction : particularité des adolescents. In Dans PICHEROT G., STHENEUR C. Addiction chez l’enfant et l’adolescent, collection Progrès en pédiatrie, Editions Douin. (): 0.
  
  
• Sauvaget A, Victorri-Vigneau C (2014) Prescription et surveillance des psychotropes : prescrire et surveiller un médicament appartenant aux principales classes de psychotropes. . In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.
  
  
• Cholet J, Victorri-Vigneau C (2014) Addiction aux médicaments psychotropes (benzodiazépines et apparentés) : repérer, diagnostiquer, évaluer le retentissement d’une addiction aux médicaments psychotropes (benzodiazépines et apparentés) ; Indications et principes du sevrage thérapeutique, ar. In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.
  
  
• Robert C, Victorri-Vigneau C, Sauvaget A (2014) Douleur en santé mentale : repérer, prévenir, et traiter les manifestations douloureuses chez le patient psychiatrique et la personne atteinte de troubles envahissant du développement ; connaître les bases en psychopathologie de la douleur aiguë et chroni. In Dans Psychiatrie, collection Référence ECN, Editions Estem de Boeck. (): 0.
  
  
• Ghosn J, Bouquié R, Viard J, Potel G (2014) Principales classes d’antibiotiques , d’antiviraux, d’antifongiques et d’antiparasitaires Prescription et surveillance. . In Dans Le bon usage du médicament et des thérapeutiques non médicamenteuses ; collection des enseignants Editions Med-line (): 0.
  
  
• Gregoire M, Deslandes G, Renaud C, Bouquié R, Allavena C, Raffi F, Jolliet P, Dailly E (2014) A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 971: 1-9.
  
  
• Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol, 69(11): 1965-1972.
  
  
• Lapeyre-Mestre M, Sapede C, Moore N, participants of round table n°5 of Giens workshops XXVIIIth: P. BILBAULT, P. BLIN, D. CHOPY, D. EVANS, F. GUEYFFIER, L. LACOIN, M. MALBEZIN, J. MICALLEF, D. MORLET-VIGIER, S. MULLER, E. OGER, Y. PLETAN, G. PONS, P. VERPILLAT and C. VIGNEAU (2013) Pharmacoepidemiology studies: what levels of evidence and how can they be reached?. Thérapie, 68(4): 241-52.
  
  
• Bellanger L, Victorri-Vigneau C, Pivette J, Jolliet P, Sébille V (2013) Discrimination of psychotropic drugs over-consumers using a threshold exceedance based approach. Statistical Analysis and Data-Mining, 6(2): 91-101.
  
  
• Clément R, Gérardin M, Victorri-Vigneau C, Guigand G, Wainstein L, Jolliet P (2013) Medical, social and law characteristics of intoxicant's users medically examined in police custody. J Forensic Leg Med, 20: 1083-6.
  
  
• Dailly E, Arnould J, Fraissinet F, Naux E, Letard de la Bouralière M, Bouquié R, Deslandes G, Jolliet P, Le Floch R (2013) Pharmacokinetics of ertapenem in burns patients. Int J Antimicrob Agents, 42: 48-52.
  
  
• Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P (2013) Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of Teicoplanin concentrations in human plasma . J Clin Lab Anal, 27: 96-8.
  
  
• Dailly E, Allavena C, Bouquié R, Deslandes G, Raffi F, Jolliet P (2013) Effect of efavirenz, nevirapine, etravirine, raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected Patients. AIDS Research and Human Retroviruses , 29(29): 42-46.
  
  
• Bouquié R, Deslandes G, Renaud C, Dailly E, Jolliet P (2013) Validation and application of a fast semi-automated whole blood extraction for LC-MS/MS simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus - Application to high throughput routine therapeutic drug monitoring. . Anal Methods , 5: 5079-5088.
  
  
• Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB (2013) Updating the French method for the causality assessment of adverse drug reactions. Thérapie, 68(2): 69-76.
  
  
• Peuvrel L, Chiffoleau A, Quéreux G, Brochard A, Saint-Jean M, Batz A, Jolliet P, Dréno B (2013) Melanoma and Rituximab: an incidental association?. Dermatology, 226(3): 275-8.
  
  
• Mahé J, Meurette A, Moreau A, Vercel C, Jolliet P (2013) Renal thrombotic microangiopathy caused by interferon beta-Ia treatment for multiple sclerosis. Drug Design, Development and Therapy , 7: 723-8.
  
  
• Ruellan AL, Bellissant E, Bourgeois H, Carlhant-Kowalski D, Douillard JY, Jamet A, Jolliet P, Lainé-Cessac P, Metges JP, Polard-Riou E, Riche C, Grude F (2013) Collaboration entre l'Observatoire dédié au cancer et les Centre régionaux de pharmacovigilance : premiers résultats sur la pharmacovigilance des médicaments anticancéreux. La Lettre du Pharmacologue, 27(2): 51-7.
  
  
• Guillou-Landreat M, Victorri-Vigneau C, Grall-Bronnec M, Sébille V, Vénisse JL, Jolliet P (2013) Impact des politiques de santé publiques sur les consultations en addictologie à partir d’un suivi longitudinal de 1998 à 2007. Ann Med Psychol , 171(6): 367-371.
  
  
• Dailly E, Papuchon E, Deslandes G, Bouquié R, Jolliet P, Cantarovich D (2013) Modified mycophenolic acid pharmacokinetics after replacement of tacrolimus by sirolimus following simultaneous pancreas/kidney transplantation. Journal of Applied Biopharmaceutics and Pharmacokinetics , 1: 1-4.
  
  
• Victorri-Vigneau C, Wainstein L, Guillet M, Gérardin M, Jolliet P (2012) Diagnostic de pharmacodépendance : comparaison des points de vue du patient et du médecin. Thérapie , 67(2): 167-172.
  
  
• Joyau C, Allain-Veyrac G, Dixneuf V, Jolliet P (2012) Anti tumor necrosis factor alpha therapy and increased risk of de novo psoriasis; is it really a paradoxical side effect?. Clin Expert Rheumatol, 30: 700-6.
  
  
• Quaglio G, Faccini M, Victorri-Vigneau C, Casari R, Mathewson S, LICATA M, Lugoboni F (2012) Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate. Subst Abus., 33(2): 195-8.
  
  
• Victorri-Vigneau C, Grall-Bronnec M, Guillou-Landreat M, Gérardin M, Wainstein L, Grosclaude C, Jolliet P (2012) Prise en charge de la douleur aiguë chez les patients sous traitements de substitution aux opiacés. Douleur et analgésie , 25: 83-86.
  
  
• Wainstein L, Victorri-Vigneau C, Jolliet P (2012) Nouvelle approche pharmaco-épidémiologique dans le champ de l’Addictovigilance. La Lettre du Pharmacologue , 26(1): 24-29.
  
  
• Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
  
  
• Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
  
  
• Pipet A, Allain-Veyrac G, Wessel F, Jolliet P, Magnan A, Demoly P, Bousquet PJ (2011) A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities. Clin Exp Allergy, 41: 1602-1608.
  
  
• Gérardin M, Victorri-Vigneau C, Louvigne C, Rivoal M, Jolliet P (2011) Management of cannabis use during pregnancy: an assessment of healthcare professionals'practices. Pharmacoepidemiol Drug Saf, 20(5): 464-73.
  
  
• Guillou-Landreat M, Sébille V, Victorri-Vigneau C, Grall-Bronnec M, Vénisse JL, Jolliet P (2011) Consommation d'opiacés. Un suivi systématisé au CHU de Nantes de 1998 à 2007 . Alcoologie et Addictologie, 33(1): 9-15.
  
  
• Wainstein L, Victorri-Vigneau C, Sébille V, Hardouin JB, Feuillet F, Pivette J, Chaslerie A, Jolliet P (2011) Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis. International Clinical Psychopharmacology, 26(1): 54-62.
  
  
• Allain-Veyrac G, Lebreton A, Collonnier C, Jolliet P (2011) First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?. Am J Clin Dermatol, 12(3): 210-213.
  
  
• Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB (2011) Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments. Thérapie, 66(6): 517-525.
  
  
• Guillou-Landreat M, Victorri-Vigneau C, Grall-Bronnec M, Sébille V, Vénisse JL, Jolliet P (2011) Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database. Encéphale, 37(6): 418-24.
  
  
• Victorri-Vigneau C, Sébille V, Gérardin M, Simon D, Pivette J, Jolliet P (2011) Epidemiological characterization of drug overconsumption: the example of antidepressants. Journal of Addictive Disease, 30(4): 342-350.
  
  
• Guillou-Landreat M, Victorri-Vigneau C, Hardouin JB, Grall-Bronnec M, Marais M, Vénisse JL, Jolliet P (2010) Can we say that seniors are addicted to Benzodiazepines?. Substance Use and Misuse, 45(12): 1988-1999.
  
  
• Jolliet P (2010) A propos des prescriptions hors-AMM. Thérapie, 65(6): 7.
  
  

Publications liées à l'axe principal de recherche (Pharmacodépendance)

• Feuillet F, Bellanger L, Hardouin JB, Victorri-Vigneau C, Sébille V (2015) On comparison of clustering methods for pharmacoepidemiological data. Journal of Biopharmaceutical Statistics, 25(4): 843-856.
  
  
• Gaboriau L, Victorri-Vigneau C, Gérardin M, Allain-Veyrac G, Jolliet P, Grall-Bronnec M (2014) Aripiprazole : a new risk factor for pathological gambling ? A report of 8 cases report. Addict Behav, 39(3): 562-5.